1-10 of 10
Wenjing Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Double-Hit/Triple-Hit Myeloma: An Adverse Prognostic Factor That Can be Overcome By Minimal Residual Disease Negativity

Yang Yang, Wenjing Wang, Liang Ren, Yawen Wang, Aziguli Maihemaiti, Tianwei Lan, Chi Zhou, Panpan Li, Pu Wang, Jing Li, Jiadai Xu, Tianhong Xu, Fei-fei Chen, Peng Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6956.
https://doi.org/10.1182/blood-2024-207788
Published: 2024
Journal Articles

Comparison of Ixazomib, Lenalidomide Plus Dexamethasone (IRd) and Bortezomib, Lenalidomide Plus Dexamethasone (VRd) in Newly Diagnosed Multiple Myeloma in China

Wenjing Wang, Jing Li, Mengyuan Li, Xiao He, LI Bao, Xiaoqiong Tang, Hua Xue, Jianmei Xu, Liye Zhong, Peng Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 5159.
https://doi.org/10.1182/blood-2024-207888
Published: 2024
Journal Articles

Clinical Implication of Minimal Residual Disease By Multiparameter Flow Cytometry in Light Chain Amyloidosis

Tianhong Xu, Jing Li, Yang Yang, Wenjing Wang, Pu Wang, Chenqi Yu, Peng Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6770.
https://doi.org/10.1182/blood-2023-184754
Published: 2023
Journal Articles

Clinical Characterization of Hepatic Light Chain Amyloidosis in the Chinese Population: A Single-Center Retrospective Analysis

Chen Chen, Chenqi Yu, Jing Li, Weiguang Wang, Zhimei Wang, Lu-Ya Cheng, Fei-fei Chen, Jiadai Xu, Tianhong Xu, Yang Yang, Wenjing Wang, Pu Wang, Peng Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6745.
https://doi.org/10.1182/blood-2023-186600
Published: 2023
Journal Articles

A Comparative Study of Clinical Characteristics, Cytogenetic Abnormalities and Outcomes Among Multiple Myeloma, Primary Light-Chain Amyloidosis and Multiple Myeloma with Concurrent AL Amyloidosis

Chenqi Yu, Jing Li, Tianhong Xu, Wenjing Wang, Pu Wang, Yang Yang, Peng Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2032.
https://doi.org/10.1182/blood-2023-188350
Published: 2023
Journal Articles

Exclusive Benefits of Sustained MRD-Negative in High-Risk Multiple Myeloma

Liang Ren, Tianhong Xu, Wenjing Wang, Yang Yang, Yawen Wang, Aziguli Maihemaiti, Tianwei Lan, Panpan Li, Chi Zhou, Pu Wang, Peng Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6663.
https://doi.org/10.1182/blood-2023-172450
Published: 2023
Journal Articles

Update on the Outcome of M-Protein Screening Program of Multiple Myeloma in China: A 7-Year Cohort Study

Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Peng Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10097–10098.
https://doi.org/10.1182/blood-2022-168200
Published: 2022
Journal Articles

Single-Cell Analyses of Immune Microenvironment Informs Potential Benefits of Dual Macrophage-Targeted Therapy in Multiple Myeloma

Jing Li, Yang Yang, Wenjing Wang, Jiadai Xu, Peng Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4255–4256.
https://doi.org/10.1182/blood-2022-166274
Published: 2022
Journal Articles

Lentiviral Short Hairpin RNA Silencing of DNM3 Decreases Megakaryoycte Progenitor Proliferation and Inhibits the Formation of the Demarcation Membrane System.

Jo Anna Reems, PhD, Wenjing Wang, M.D./Ph.D, Sun Sijie, Xiaoping Wu, Diana M. Gilligan, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4594.
https://doi.org/10.1182/blood.V114.22.4594.4594
Published: 2009
Journal Articles

Dynamin 3 Is Differentially Expressed during Human Megakaryocyte Development.

Jo Anna Reems, PhD, Wenjing Wang, MD/PhD, Ken Tsubata, Birgitta Sundell, PhD, Diana M. Gilligan, MDPhD
Journal: Blood
Blood (2006) 108 (11): 4162.
https://doi.org/10.1182/blood.V108.11.4162.4162
Published: 2006